EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increasing the Passive Range of Joint Motion in Stroke Patients Using Botulinum Toxin: The Role of Pain Relief

Carlo Trompetto iD, Lucio Marinelli iD, Laura Mori, Nicola Bragazzi, Giulia Maggi, Filippo Cotellessa, Luca Puce iD, Lucilla Vestito iD, Franco Molteni, Giulio Gasperini iD, Nico Farina, Luciano Bissolotti und 10 weitere

Toxins · 13.05.2023 · 15 (5) · 335

DOI: 10.3390/toxins15050335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, online erschienen am 13.05.2023. Verfasst von Carlo Trompetto und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16132 Genoa, GE, Italy. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Stroke, Neuromuscular Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “5 × 1000” Italian donation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

By blocking the release of neurotransmitters, botulinum toxin A (BoNT-A) is an effective treatment for muscle over-activity and pain in stroke patients. BoNT-A has also been reported to increase passive range of motion (p-ROM), the decrease of which is mainly due to muscle shortening (i.e., muscle contracture). Although the mechanism of action of BoNT-A on p-ROM is far from understood, pain relief may be hypothesized to play a role. To test this hypothesis, a retrospective investigation of p-ROM and pain was conducted in post-stroke patients treated with BoNT-A for upper limb hypertonia. Among 70 stroke patients enrolled in the study, muscle tone (Modified Ashworth Scale), pathological postures, p-ROM, and pain during p-ROM assessment (Numeric Rating Scale, NRS) were investigated in elbow flexors (48 patients) and in finger flexors (64 patients), just before and 3–6 weeks after BoNT-A treatment. Before BoNT-A treatment, pathological postures of elbow flexion were found in all patients but one. A decreased elbow p-ROM was found in 18 patients (38%). Patients with decreased p-ROM had higher pain-NRS scores (5.08 ± 1.96, with a pain score ≥8 in 11% of cases) than patients with normal p-ROM (0.57 ± 1.36) (p < 0.001). Similarly, pathological postures of finger flexion were found in all patients but two. A decreased finger p-ROM was found in 14 patients (22%). Pain was more intense in the 14 patients with decreased p-ROM (8.43 ± 1.74, with a pain score ≥ 8 in 86% of cases) than in the 50 patients with normal p-ROM (0.98 ± 1.89) (p < 0.001). After BoNT-A treatment, muscle tone, pathological postures, and pain decreased in both elbow and finger flexors. In contrast, p-ROM increased only in finger flexors. The study discusses that pain plays a pivotal role in the increase in p-ROM observed after BoNT-A treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AStrokeNeuromuscular AgentsHumansRetrospective StudiesMuscle SpasticityUpper ExtremityTreatment OutcomePain

Stichwörter der Autor:innen

limb posturespathological posturesspastic dystoniaspasticitystretch

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16132 Genoa, GE, Italy.
  • IRCCS Ospedale Policlinico San Martino, Division of Neurorehabilitation, Department of Neuroscience, 16132 Genoa, GE, Italy.
  • IRCCS Ospedale Policlinico San Martino, Division of Clinical Neurophysiology, Department of Neuroscience, 16132 Genoa, GE, Italy.
  • Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University, Toronto, ON M3J 1P3, Canada.
  • Villa Beretta Rehabilitation Center, 23845 Costa Masnaga, LC, Italy.
  • Rehabilitation Service, Fondazione Teresa Camplani Casa di Cura Domus Salutis, 25123 Brescia, BS, Italy.

ORCID-Profile: Carlo Trompetto, Lucio Marinelli, Luca Puce, Lucilla Vestito, Giulio Gasperini, Andrea Santamato, Alessandra Del Felice, Antonio Currà

Förderung

  • “5 × 1000” Italian donation program

Zitieren

APA

Trompetto, C., Marinelli, L., Mori, L., Bragazzi, N., Maggi, G., Cotellessa, F., Puce, L., Vestito, L., Molteni, F., Gasperini, G., Farina, N., Bissolotti, L., Sciarrini, F., Millevolte, M., Balestrieri, F., Restivo, D. A., Chisari, C., Santamato, A., Del Felice, A., …, & Currà, A. (2023). Increasing the Passive Range of Joint Motion in Stroke Patients Using Botulinum Toxin: The Role of Pain Relief. Toxins, 15(5), 335. https://doi.org/10.3390/toxins15050335

Vancouver

Trompetto C, Marinelli L, Mori L, Bragazzi N, Maggi G, Cotellessa F, et al. Increasing the Passive Range of Joint Motion in Stroke Patients Using Botulinum Toxin: The Role of Pain Relief. Toxins. 2023;15(5):335. doi:10.3390/toxins15050335

BibTeX
@article{Trompetto2023,
  author = {Trompetto, Carlo and Marinelli, Lucio and Mori, Laura and Bragazzi, Nicola and Maggi, Giulia and Cotellessa, Filippo and Puce, Luca and Vestito, Lucilla and Molteni, Franco and Gasperini, Giulio and Farina, Nico and Bissolotti, Luciano and Sciarrini, Francesco and Millevolte, Marzia and Balestrieri, Fabrizio and Restivo, Domenico Antonio and Chisari, Carmelo and Santamato, Andrea and Del Felice, Alessandra and Manganotti, Paolo and Serrati, Carlo and Currà, Antonio},
  title = {Increasing the Passive Range of Joint Motion in Stroke Patients Using Botulinum Toxin: The Role of Pain Relief},
  journal = {Toxins},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {335},
  doi = {10.3390/toxins15050335}
}
Kostenlos starten →